Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-43,009
Closed -$3.3M 249
2024
Q4
$3.3M Buy
+43,009
New +$3.72M 0.47% 113
2024
Q2
Sell
-66,052
Closed -$4.59M 243
2024
Q1
$4.59M Buy
66,052
+1,000
+2% +$63.4K 0.72% 25
2023
Q4
$3.61M Buy
+65,052
New +$2.93M 0.64% 67
2023
Q3
Sell
-55,714
Closed -$1.76M 274
2023
Q2
$1.76M Sell
55,714
-48,587
-47% -$1.86M 0.33% 135
2023
Q1
$3.21M Sell
104,301
-24,224
-19% -$735K 0.63% 30
2022
Q4
$3.98M Sell
128,525
-761
-0.6% -$17.5K 0.82% 10
2022
Q3
$2.43M Sell
129,286
-1,524
-1% -$29.2K 0.53% 65
2022
Q2
$2.37M Buy
+130,810
New +$1.69M 0.58% 53

Other funds holding ACLX

EAM Investors's ACLX Position: Q1 2025 in Review

EAM Investors sold out of Arcellx (ACLX) in Q1 2025, closing a stake of 43,009 shares — an estimated $3.3M sold.

EAM Investors first reported a position in ACLX in Q2 2022 and held it in 8 quarters. The position peaked at $4.59M in Q1 2024. 197 funds tracked by Wall St. Rank hold ACLX as of Q1 2025.

  • EAM Investors reported no remaining Arcellx position as of Q1 2025 after selling out during the quarter.
  • EAM Investors sold 43,009 Arcellx shares in Q1 2025, an estimated $3.3M.
  • EAM Investors first reported a position in Arcellx in Q2 2022 and held it in 8 quarters.
  • EAM Investors's Arcellx position peaked at $4.59M in Q1 2024.
  • 197 funds tracked by Wall St. Rank held Arcellx as of Q1 2025.

Based on EAM Investors's 13F filing for Q1 2025, filed 13 May 2025.